NASDAQ
DiaMedica Therapeutics Inc.
DMAC $521M
Cap as of Nov 11 0 stories
Get DMAC news in Claude, ChatGPT or your own code. See plans
Nothing on DiaMedica Therapeutics Inc. yet
We have this company on file, but there is nothing here to read about it.
Investor Letters
Letters that discuss DMAC.
- 1 Main Capital Q2 2026 - Letter second quarter 2026 DMAC $521MHGV $3.4B